Description:
Home Page: serinatherapeutics.com
601 Genome Way
Huntsville,
AL
35806
United States
Phone:
256 327 9630
Officers
| Name | Title |
|---|---|
| Mr. Steven A. Ledger | Interim CEO & Director |
| Dr. Randall W. Moreadith M.D., Ph.D. | Chief Scientific Officer |
| Dr. Balkrishan Gill Ph.D. | Executive Chairman |
| Ms. Eun-Jae Park CPA | Interim CFO & Chief Accounting Officer |
| Dr. Srini Tenjarla | Senior Vice President of Chemistry, Manufacturing & Controls and Formulation |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2018-11-29 |
| Fiscal Year End: | December |
| Full Time Employees: | 9 |